一个可空间控制的基于DNA的T细胞集群激活器用于精确的瘤消除
Hua-Dong Li1,2, Wen-Jia Shi1, Jianjun Xu3
1Lab of Biosystem and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
Journal of the American Chemical Society
|January 8, 2026
概括
时空T细胞集群诱导剂 (SpTCE) 提供受控的免疫瘤学. 这种DNA原形技术增强了T细胞对瘤的激活, 提高了癌症治疗的安全性和有效性.
科学领域:
- 生物技术
- 免疫学
- 纳米技术
背景情况:
- 用T细胞治疗是一种有前途的免疫瘤治疗方法.
- 目前的疗法在有效性和安全性方面面临挑战,限制了临床应用.
研究的目的:
- 通过使用DNA原始技术引入时空T细胞集群参与者 (SpTCE).
- 设计一个可空间控制的T细胞激活器, 提高效率和安全性.
主要方法:
- 开发了一种两层DNA原始结构 (SpTCE),其中一个内部功能层用于T细胞聚类,一个外部屏蔽层用于pH反应控制.
- 集成的白蛋白结合域和i-motif开关,用于pH触发的T细胞激活和提高稳定性.
- 在实验室和体内验证了SpTCE的性能,并将其与临床阶段的双特异性T细胞吸引剂进行比较.
主要成果:
- 在实验室中,SpTCE对瘤细胞表现出酸性pH触发的特异性细胞毒性.
- 在体内观察到大量的内积累和改善的生理稳定性.
- 它有效地重定向T细胞以消除具有高特异性和有利的瘤外毒性.
结论:
- 在先进的免疫瘤学中,SpTCE具有作为T细胞激活剂的潜力.
- 实现了对T细胞激活的精确控制,平衡了疗效和安全性.
- 这种技术扩大了癌症治疗的可能性.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K


